Recent Progress in the Treatment of Acute Lymphoblastic Leukemia, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Authors :
Wendy Stock & Meir Wetzler
Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2
...view more
Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp.
Your discount code here : #FB456
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYS
Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp.
Author Information
By Wendy Stock, MD and Meir Wetzler, MD
ISBN Number | 9781437712278 |
---|---|
Main Author | By Wendy Stock, MD and Meir Wetzler, MD |
Copyright Year | 2009 |
Edition Number | 1 |
Format | Book |
Trim | 152w x 229h |
Imprint | Saunders |
Page Count | 0 |
Publication Date | 3 Nov 2009 |
Stock Status | IN STOCK - This may take up to 5 business days to ship |
Write Your Own Review
Only registered users can write reviews. Please sign in or create an account
product
https://www.us.elsevierhealth.com/recent-progress-in-the-treatment-of-acute-lymphoblastic-leukemia-an-issue-of-hematologyoncology-clinics-of-north-america-9781437712278.html
6085
Recent Progress in the Treatment of Acute Lymphoblastic Leukemia, An Issue of Hematology/Oncology Clinics of North America
https://www.us.elsevierhealth.com/media/catalog/product/9/7/9781437712278.jpg
62.99
89.99
USD
InStock
/Medicine/Hematology
/Clinics
/Clinics
137
4388725
5255041
Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp. Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp.
0
0
add-to-cart
9781437712278
2011 and earlier
Professional
By Wendy Stock, MD and Meir Wetzler, MD
2009
1
Book
152w x 229h
Saunders
0
Nov 3, 2009
IN STOCK - This may take up to 5 business days to ship
By <STRONG>Wendy Stock</STRONG>, MD and <STRONG>Meir Wetzler</STRONG>, MD
Clinics
Clinics
The Clinics: Internal Medicine
No
No
No
No
Please Select
Please Select
Please Select
Related Products
-
15% OFF BookThe Netter Collection of Medical Illustrations: Endocrine System, Volume 2
William F. Young
Jun 2024
Special Price $91.79 $107.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Musculoskeletal System, Volume 6, Part I - Upper Limb
Edited by Joseph Iannotti
Mar 2024
Special Price $91.79 $107.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Reproductive System, Volume 1
Roger Smith
Jun 2024
Special Price $84.99 $99.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Urinary System, Volume 5
Edited by Roshan Patel
Jun 2024
Special Price $84.99 $99.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Musculoskeletal System, Volume 6, Part III - Biology and Systemic Diseases
Edited by Joseph Iannotti
Mar 2024
Special Price $91.79 $107.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Respiratory System, Volume 3
Edited by David A. Kaminsky
May 2024
Special Price $84.99 $99.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part I - Brain
Edited by Michael J. Aminoff
Mar 2024
Special Price $84.99 $99.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Musculoskeletal System, Volume 6, Part II - Spine and Lower Limb
Edited by Joseph P Iannotti
Mar 2024
Special Price $91.79 $107.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Cardiovascular System, Volume 8
Jamie B. Conti
Mar 2024
Special Price $91.79 $107.99 -
15% OFF BookThe Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part II - Spinal Cord and Peripheral Motor and Sensory Systems
Edited by Michael J. Aminoff
Mar 2024
Special Price $84.99 $99.99